CEFOPERAZONE 1000mg. IP + SULBACTAM 500mg. IP

A broad-spectrum cephalosporin antibiotic is used for the treatment of several bacterial infections. (Ming-Jen Sheu, 2020) Produces significant synergistic antibacterial activity against gram-negative bacteria. (Xiao-Xia Wang, 2021) Possesses stronger antibacterial potency than cefoperazone alone against E. coli. (S Iwata, 1984) An effective and safe drug for respiratory tract infections caused by beta-lactamase-producing as well as beta-lactamase non-producing bacteria. (H Koga, 1996) Shows high efficacy in the treatment of severe nosocomial infections and infectious endocarditis. (N V Beloborodova, 2005) As effective as piperacillin-tazobactam in the management of adult patients with hospital-acquired pneumonia and ventilator-associated pneumonia. (Chia-Hung Chen, 2021) A very useful drug in the treatment of lower respiratory tract infections. (T Ishibashi, 1990) An effective antibiotic for the treatment of severe infections in the presence of concurrent hematologic diseases. (A Horiuchi, 1989) A cheaper alternative to meropenem against gram-negative bacilli. (N Poudyal, 2012) A therapeutic option for the treatment of patients with febrile neutropenia. (Shao-Huan Lan, 2020)